BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10764140)

  • 1. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.
    McLeod HL; Krynetski EY; Relling MV; Evans WE
    Leukemia; 2000 Apr; 14(4):567-72. PubMed ID: 10764140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.
    Relling MV; Hancock ML; Rivera GK; Sandlund JT; Ribeiro RC; Krynetski EY; Pui CH; Evans WE
    J Natl Cancer Inst; 1999 Dec; 91(23):2001-8. PubMed ID: 10580024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Forestier E; Kristinsson J; Söderhäll S; Vettenranta K; Weinshilboum R; Wesenberg F;
    Leukemia; 2009 Mar; 23(3):557-64. PubMed ID: 18987654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
    Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.
    McLeod HL; Relling MV; Liu Q; Pui CH; Evans WE
    Blood; 1995 Apr; 85(7):1897-902. PubMed ID: 7703493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.
    Krynetski EY; Tai HL; Yates CR; Fessing MY; Loennechen T; Schuetz JD; Relling MV; Evans WE
    Pharmacogenetics; 1996 Aug; 6(4):279-90. PubMed ID: 8873214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies.
    Franca R; Braidotti S; Stocco G; Decorti G
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1187-1198. PubMed ID: 34452592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
    Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Karas-Kuzelicki N; Mlinaric-Rascan I
    Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon.
    Zgheib NK; Akika R; Mahfouz R; Aridi CA; Ghanem KM; Saab R; Abboud MR; Tarek N; El Solh H; Muwakkit SA
    Pediatr Blood Cancer; 2017 Jan; 64(1):146-150. PubMed ID: 27577869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
    Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
    Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
    Kapoor G; Sinha R; Naithani R; Chandgothia M
    Leuk Res; 2010 Aug; 34(8):1023-6. PubMed ID: 20153897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia.
    McLeod HL; Coulthard S; Thomas AE; Pritchard SC; King DJ; Richards SM; Eden OB; Hall AG; Gibson BE
    Br J Haematol; 1999 Jun; 105(3):696-700. PubMed ID: 10354134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine-Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia.
    Schwarz UI; Woldanski-Travaglini M; Swanston V; Mikhail M; Cacciotti C; Cairney E; Patel S; Seelisch J; Tole S; Wilejto M; Tirona RG; Kim RB; Zorzi AP
    Clin Pharmacol Ther; 2023 Jun; 113(6):1326-1336. PubMed ID: 36932910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.
    Hongeng S; Sasanakul W; Chuansumrit A; Pakakasama S; Chattananon A; Hathirat P
    Med Pediatr Oncol; 2000 Oct; 35(4):410-4. PubMed ID: 11025471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.
    Jiménez-Morales S; Ramírez-Florencio M; Mejía-Aranguré JM; Núñez-Enríquez JC; Bekker-Mendez C; Torres-Escalante JL; Flores-Lujano J; Jiménez-Hernández E; Del Carmen Rodríguez-Zepeda M; Leal YA; González-Montalvo PM; Pantoja-Guillen F; Peñaloza-Gonzalez JG; Gutiérrez-Juárez EI; Núñez-Villegas NN; Pérez-Saldivar ML; Guerra-Castillo FX; Flores-Villegas LV; Ramos-Cervantes MT; Fragoso JM; García-Escalante MG; Del Carmen Pinto-Escalante D; Ramírez-Bello J; Hidalgo-Miranda A
    Arch Med Res; 2016 Nov; 47(8):615-622. PubMed ID: 28476189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
    Lennard L; Cartwright CS; Wade R; Richards SM; Vora A
    Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of TPMT testing.
    Lennard L
    Br J Clin Pharmacol; 2014 Apr; 77(4):704-14. PubMed ID: 23962279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.